#JITC Commentary: Challenges in assessing the clinical utility and economic value of immune checkpoint inhibitor therapies of Cancer https://t.co/UVd6WQm47k
7,957 followers
438 followers
RT @sitcancer: New #JITC Commentary: Challenges in assessing the clinical utility and economic value of immune checkpoint inhibitor therapi…
2,677 followers
RT @sitcancer: New #JITC Commentary: Challenges in assessing the clinical utility and economic value of immune checkpoint inhibitor therapi…
19,075 followers
New #JITC Commentary: Challenges in assessing the clinical utility and economic value of immune checkpoint inhibitor therapies of Cancer https://t.co/ZhDzzkTubQ